Drs. Rajiv Gulati, and John Stulak discusses the advancement of VADs and their role as a destination therapy in treating patients with advanced heart failure.
Publish Date: 10/30/2012
Low T - Health Risks of Testosterone Therapy - Mayo Clinic. Dr. William Young.
Publish Date: 10/8/2014
A Mayo Clinic study has identified a familial association in spontaneous coronary artery dissection, a type of heart attack that most commonly affects younger woman, suggesting a genetic predisposition to the condition, researchers say. The results are published in the March 23 issue of JAMA Internal Medicine.
Publish Date: 8/5/2015
Randal Thomas, M.D., M.S., presents Mythbusters in Preventive Cardiology.
Publish Date: 1/30/2014
Grand Rounds: Melody Valve Therapy Overview: Transcatheter Pulmonary Valve and Tricuspid/Mitral Valve-in-Valve
Allison Cabalka, M.D., presents Melody Valve Therapy Overview: Transcatheter Pulmonary Valve and Tricuspid/Mitral Valve-in-Valve.
Publish Date: 3/17/2014
Choose a topic:
All Cardiovascular Diseases (114)
Coronary Calcium Score: Basics and Beyond
In this recording previously posted on Medscape Cardiology, Mayo Clinic assistant professor of medicine, Naveen Periera, M.D., and Iftikhar Kullo, professor of medicine, discuss coronary calcium testing as a predictor of heart disease.
Fibromuscular Dysplasia: A Mystery of Vascular Medicine
Mayo Clinic vascular specialists, Robert McBane, M.D., Thom Rooke, M.D., Sanjay Misra, M.D., and Iftikhar Kullo, M.D., cover the rare disorderfibromuscular dysplasia in this video originally posted on Medscape Cardiology.
Cardiac Amyloidosis – The Great Imitator
Mayo Clinic cardiologist and director of the Cardiac Amyloid Clinic, Martha Grogan, M.D., Angela Dispenzieri, M.D., professor of laboratory medicine and pathology, and Nandan Anavekar, M.B., B.Ch., senior associate professor of medicine talk about cardiac amyloidosis.
Engaging Underrepresented Populations in Medical Research
A conversation about the perceptions and attitudes toward health-related research participation among African-American women.
Statin Intolerance and Diabetes Risk: What Do We Know?
Mayo Clinic director of Exercise Testing and Sports Cardiology, Thomas Allison, M.D., Francisco Lopez-Jimenez, M.D., director of Preventative Cardiology, and Vinaya Simha, M.D., endocrinologist and specialist in lipidology discuss statin intolerance.
Drilling Down on the Cholesterol Treatment Guidelines
A discussion about the American College of Cardiology/American Heart Association guidelines on the treatment of blood cholesterol.
PCI and ACS: Where Do Vorapaxar and Bivalirudin Fit In?
Mayo Clinic Assistant Professor of Cardiology and Pharmacology, Naveen Pereira M.D., and Gurpreet Sandhu M.D., Ph.D., Director of the Cardiac Catheterization Laboratory discuss adjunctive pharmacotherapy and coronary artery disease, with an emphasis on anticoagulation and antiplatelet drugs.
Right Ventricular Dysfunction in HFpEF: No Innocent Bystander
A discussion about right ventricular function in heart failure with preserved ejection fraction and right heart dysfunction in heart failure with preserved ejection fraction.